Right Heart Dysfunction in Valvular Heart Disease
JACC · 2026-11 · 88 (19) · 2221-2243
DOI: 10.1016/j.jacc.2026.08.035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC, 2026-11. Verfasst von Michael I Brener und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Columbia University Medical Center, New York, New York, USA. Electronic address: mib2102@cumc.columbia.edu. Hauptthemen laut MEDLINE: Ventricular Dysfunction, Right, Heart Valve Diseases, Disease Management. Die Arbeit nennt 176 Literaturangaben. Gefördert von: NIH.
Abstract (Originalsprache)
Right ventricular (RV) dysfunction is an important determinant of clinical outcomes across a wide range of cardiovascular pathologies. As the prevalence of valvular heart disease (VHD) increases with the aging population, the intersection between RV function and VHD will become all the more relevant for proper risk assessment, treatment selection, and prognostication. Even though RV dysfunction may not always be attributed to VHD, we aim to give clinicians, researchers, and regulators a deep understanding of how patients with VHD should be evaluated for RV dysfunction and treated when RV dysfunction coexists with VHD. We begin with a discussion of the epidemiology and diagnostic evaluation of RV dysfunction in patients with a variety of VHD subgroups, including right-side (ie, associated with the tricuspid valve) and left-side (ie, associated with the mitral and aortic valves) VHD. Attention is also given in that section to contemporary methods and evolving techniques for identifying and phenotyping different forms of RV dysfunction in patients with VHD. No single imaging test practically or comprehensively captures all degrees and forms of RV dysfunction in patients with VHD; therefore, the discussion emphasizes integrating evidence from different imaging modalities and hemodynamic assessments. The second component of the review discusses how RV dysfunction affects therapeutic options, including medical, transcatheter, and surgical therapies for VHD. The focus of the discussion is on the interplay between RV dysfunction in patients with right-side VHD, namely tricuspid regurgitation (TR). Unlike left-side VHD, where RV dysfunction is a marker of overall disease severity but does not necessarily indicate futility or nonresponse to therapy, right-side VHD and TR-associated RV dysfunction identifies a subset of patients where intervention may precipitate even worse RV function. The nuances of these interactions between ventricular and valvular function are the emphasis of this section, and we aim to provide a framework for understanding RV function in the context of these different forms of VHD. Finally, the review concludes with an eye to the future, discussing the ways in which RV dysfunction can be identified and managed with the use of novel techniques. This discussion is increasingly relevant as RV dysfunction and VHD frequently coexist, and accurate identification is critical to matching the right treatment for the right patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Columbia University Medical Center, New York, New York, USA. Electronic address: mib2102@cumc.columbia.edu.
- Department of Medicine-Surgery, University of Milano-Bicocca, Milan, Italy; Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
- Department of Cardiology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Division of Cardiology and Department of Cardiovascular Surgery, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Cardiology, Department of Medicine I, LMU University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance,…
Förderung
- NIH
Zitieren
APA
Brener, M. I., Badano, L. P., Galloo, X., Muraru, D., Pinney, S. P., McLaughlin, V. V., Hausleiter, J., Lurz, P., Le Ruz, R., van Mieghem, N. M., Weckbach, L. T., Ailawadi, G., Praz, F., Lindman, B. R., Salavitabar, A., Chehab, O., Stocker, T. J., Lindenfeld, J., Leon, M. B., …, & Hahn, R. T. (2026). Right Heart Dysfunction in Valvular Heart Disease. JACC, 88(19), 2221-2243. https://doi.org/10.1016/j.jacc.2026.08.035
Vancouver
Brener MI, Badano LP, Galloo X, Muraru D, Pinney SP, McLaughlin VV, et al. Right Heart Dysfunction in Valvular Heart Disease. JACC. 2026;88(19):2221-2243. doi:10.1016/j.jacc.2026.08.035
BibTeX
@article{Brener2026,
author = {Brener, Michael I and Badano, Luigi P and Galloo, Xavier and Muraru, Denisa and Pinney, Sean P and McLaughlin, Vallerie V and Hausleiter, Jörg and Lurz, Philip and Le Ruz, Robin and van Mieghem, Nicolas M and Weckbach, Ludwig T and Ailawadi, Gorav and Praz, Fabien and Lindman, Brian R and Salavitabar, Arash and Chehab, Omar and Stocker, Thomas J and Lindenfeld, Joann and Leon, Martin B and Burkhoff, Daniel and Hahn, Rebecca T},
title = {Right Heart Dysfunction in Valvular Heart Disease},
journal = {JACC},
year = {2026},
volume = {88},
number = {19},
pages = {2221--2243},
doi = {10.1016/j.jacc.2026.08.035}
}
EUVIMED